Cara Robb
Nurse Practitioner · Brandon, MSNPI 1912423989
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 226 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $4,062 and has fallen 99.5% since, to $22 in 2025. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $26.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- SK Life Science, Inc.$621
- AbbVie$560
- Teva Pharmaceuticals USA, Inc.$556
- Si-bone, Inc.$545
- Avanir Pharmaceuticals, Inc.$336
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$671%
- Travel & lodging$2684%
- Food & beverage$5,54093%
- Education$902%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 37 | $1,190 |
| SK Life Science, Inc. | 23 | $621 |
| AbbVie(2 entities) | 31 | $560 |
| Teva Pharmaceuticals USA, Inc. | 24 | $556 |
| Si-bone, Inc. | 3 | $545 |
| Avanir Pharmaceuticals, Inc. | 9 | $336 |
| Novartis | 10 | $244 |
| Sanofi | 9 | $178 |
| Amgen(2 entities) | 13 | $171 |
| AstraZeneca | 9 | $166 |
| Lundbeck LLC | 2 | $138 |
| UCB, Inc. | 11 | $131 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Neurelis, Inc. | 1 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $92 |
| Acorda Therapeutics, Inc | 4 | $90 |
| Acadia Pharmaceuticals Inc | 5 | $88 |
| Kyowa Kirin, Inc. | 4 | $87 |
| CSL Behring | 1 | $80 |
| Biogen | 5 | $77 |
| Lilly USA, LLC | 3 | $42 |
| EMD Serono, Inc. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Upsher-smith Laboratories LLC | 2 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $21 |
| Genentech USA, Inc. | 1 | $17 |
| Catalyst Pharmaceuticals, Inc. | 1 | $17 |
| Abbott | 1 | $15 |
| Bristol Myers Squibb | 1 | $12 |
| Neurocrine Biosciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iFuse Implant$402
- NUEDEXTA$368
- NURTEC ODT$227
- AJOVY$125
- UBRELVY$120
How this compares
$5,965 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Brandon
- Heather KurigerBrandon$11K
- Erin BassBrandon$9K
- Shelly BilbroBrandon$8K
- Christina TreppendahlRidgeland$125K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Sara KlausFlowood$48K
- Micaela PerkinsOxford$32K
- Michelle TharpJackson$28K
- Kaylon LewisHattiesburg$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.